Weight Loss Injection (Clinician's Choice)

Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight loss medications with clinically proven active ingredients for weight loss. These medications target brain receptors, suppressing appetite and slowing stomach emptying. This leads to reduced calorie intake and more significant weight loss than dieting alone.

During your online consultation, after an initial eligibility assessment, our doctor will help you select either Mounjaro or Wegovy based on your individual needs and conditions.

Application:

Both medications are administered as a weekly injection on the same day, at any time, with or without meals. They are injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm—never into a vein or muscle.

Side Effects:

Like all medications, some people may experience side effects. The most common are digestive issues such as nausea, diarrhoea, and gas.

Learn More about Wegovy Learn More about Mounjaro

For detailed information about these medications, including full prescribing information, safety data, and usage instructions, please visit the official manufacturer websites: Wegovy (www.wegovy.com) by Novo Nordisk and Mounjaro (www.mounjaro.com) by Eli Lilly. Additional regulatory information can be found in the electronic medicines compendium at www.medicines.org.uk .